Clindamycin
- Product NDC
- 67457-815
- 11-digit product format
- 674570815
- Labeler code
- 67457
- Product ID
- 67457-815_6344c165-6ee6-4624-afb9-ebfb66fd783e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Clindamycin
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Mylan Institutional LLC
- Application
- ANDA204748
- Marketing category
- ANDA
- Marketing start
- 2017-11-29
- Marketing end
- 0000-00-00
- Substance
- CLINDAMYCIN
- Active strength
- 150 mg/mL
- Pharmacologic classes
- Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 67457-815-04 | 67457081504 | 25 VIAL, SINGLE-DOSE in 1 CARTON (67457-815-04) > 4 mL in 1 VIAL, SINGLE-DOSE (67457-815-00) | 2017-11-29 | 2022-03-31 | No | No | Current |